SC Ropharma (BSE:RPH) Retained Earnings: lei30 Mil (As of Dec. 2024)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

BSE:RPH SC Ropharma SA BSE:RPH
66 GF Score
Price lei0.22
View Full Analysis

What is SC Ropharma Retained Earnings?

SC Ropharma BSE:RPH 66 Retained Earnings is lei30 Mil as of Dec. 2024. GuruFocus rates BSE:RPH with a GF Score™ of 66/100.

Retained earnings is the accumulated portion of net income that is not distributed to shareholders. SC Ropharma's retained earnings for the quarter that ended in Dec. 2024 was lei30 Mil.

SC Ropharma's quarterly retained earnings declined from Dec. 2023 (lei44 Mil) to Jun. 2024 (lei29 Mil) but then increased from Jun. 2024 (lei29 Mil) to Dec. 2024 (lei30 Mil).

SC Ropharma's annual retained earnings declined from Dec. 2022 (lei57 Mil) to Dec. 2023 (lei44 Mil) and declined from Dec. 2023 (lei44 Mil) to Dec. 2024 (lei30 Mil).


SC Ropharma  (BSE:RPH) Retained Earnings Explanation

Historically profitable companies sometimes have negative retained earnings. This is because they have cumulatively paid out more to shareholders than they reported in profits.

For example, in 2011, Microsoft had negative retained earnings. This does not mean the company lost more money than it made over the years. It just means it paid out more money than it earned.

If a company has negative retained earnings, investors should check the 10-year financial results. They should not assume that negative retained earnings prove a company has generally lost money in the past.

Of course, many companies with negative retained earnings have indeed lost money in the past.

Retained Earnings: Warren Buffett's Secret.

One of the most important indicators of durable competitive advantage. Net earnings can be paid out as dividends, used to buy back shares or retained for growth.

If the company loses more than it has accumulated, retained earnings is negative.

If a company isn't adding to its retained earnings, it isn't growing its net worth.

Rate of growth of retained earnings is good indicator whether it's benefiting from a competitive advantage.

Microsoft is negative because it chose to buyback stock and pay dividends.

The more earnings retained, the faster it grows and increases growth rate for future earnings.


SC Ropharma Retained Earnings Historical Data

* Premium members only.

The historical data trend for SC Ropharma's Retained Earnings can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

SC Ropharma Retained Earnings Chart

SC Ropharma Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Retained Earnings
Get a 7-Day Free Trial Premium Member Only Premium Member Only 49.35 56.74 57.41 44.48 30.05

SC Ropharma Semi-Annual Data
Dec13 Dec14 Dec15 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24
Retained Earnings Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 57.41 42.14 44.48 28.91 30.05
BSE:RPH
66GF Score
SC Ropharma SA BSE:RPH
Retained Earnings is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

SC Ropharma Retained Earnings Calculation

Retained Earnings is the accumulated portion of net income that is not distributed to shareholders. Because the net income was not distributed to shareholders, shareholders' equity is increased by the same amount.

Of course, if a company loses, it is called retained losses, or accumulated losses.

Frequently Asked Questions Learn more about Retained Earnings →
What does a Retained Earnings of lei30 Mil mean?
SC Ropharma (BSE:RPH) has a Retained Earnings of lei30 Mil as of Dec. 2024. Retained earnings is the amount of net income not issued to shareholders. View historical data on SC Ropharma and its competitors.
Is SC Ropharma's Retained Earnings too high?
SC Ropharma's current Retained Earnings is lei30 Mil. Overall, SC Ropharma has a GF Score™ of 66/100, reflecting its overall financial health beyond just this single metric.
How does SC Ropharma's Retained Earnings compare to competitors?
SC Ropharma's Retained Earnings of lei30 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Retained Earnings for a Healthcare Providers & Services company?
A good Retained Earnings depends on the Healthcare Providers & Services industry context. However, Retained Earnings should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Retained Earnings mean?
A high Retained Earnings can signal that a stock is expensive relative to its fundamentals. Retained earnings is the amount of net income not issued to shareholders. View historical data on SC Ropharma and its competitors. SC Ropharma's current Retained Earnings is lei30 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is SC Ropharma stock overvalued right now?
SC Ropharma (BSE:RPH) has a current Retained Earnings of lei30 Mil. The current Retained Earnings is lei30 Mil. SC Ropharma's overall GF Score™ is 66/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Retained Earnings calculated?
Retained Earnings is calculated from a company's financial statements. For SC Ropharma (BSE:RPH), the current Retained Earnings is lei30 Mil as of Dec. 2024. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

SC Ropharma Business Description

Address Strada Iuliu Maniu Nr. 55, ETAJ 1, Brasow, ROU, 500091
SC Ropharma SA is engaged in the production, distribution, and Retail sale of pharmaceutical products in specialized stores. Its product portfolio comprises over 50 products in the form of tablets, powders, capsules, and syrups covering 21 therapeutic areas.
66GF Score

Get the complete analysis for BSE:RPH

Retained Earnings is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

lei0.22
Price